[1]Berndt J, Kloting N, Kralisch S, Kovacs P, Fasshauer M, Schon M R, Stumvoll M, Bluher M. 2005. Plasma visfatin concentrations and fat depot-specific expression in humans. Diabetes, 54, 2911-2916. [2]Berulava T, Horsthemke B. 2010. The obesity-associated SNPs in intron 1 of the FTO gene affect primary transcript levels. European Journal of Human Genetics, 18, 1054-1056. [3]Bland J M, Altman D G. 1995. Multiple significance tests: the bonferroni method. British Medical Journal, 310, 170-170. [4]Bottcher Y, Teupser D, Enigk B, Berndt J, Kloting N, Schon M R, Thiery J, Bluher M, Stumvoll M, Kovacs P. 2006. Genetic variation in the visfatin gene (PBEF1) and its relation to glucose metabolism and fat-depot-specific messenger ribonucleic acid expression in humans. Journal of Clinical Endocrinology & Metabolism, 91, 2725-2731. [5]Botstein D, White R L, Skolnick M, Davis R W. 1980. Construction of a genetic linkage map in man using restriction fragment length polymorphisms. American Journal of Human Genetics, 32, 314-331. [6]Christopher H, Harvey F. 2005. Lodish visfatin: a new adipokine. Science, 21, 366-367. [7]Dominik G H, Ammon H, Angela S, Elena V. 2007. Visfatin response to glucose is reduced in women with gestational diabetes mellitus diabetes care. Agriculture Journals, 307, 1889-1891. [8]Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, Matsuki Y, Murakami M, Ichisaka T, Murakami H, et al. 2005. Visfatin: A protein secreted by visceral fat that mimics the effects of insulin. Science, 307, 426-430. [9]Greenwood T A, Kelsoe J R. 2003. Promoter and intronic variants affect the transcriptional regulation of the human dopamine transporter gene. Genomics, 82, 511-520. [10]Han R L, Lan X Y, Zhang L Z, Ren G, Jing Y J, Li M J, Zhang B, Zhao M, Guo Y K, Kang X T, et al. 2010. A novel single-nucleotide polymorphism of the visfatin gene and its associations with performance traits in the chicken. Journal of Applied Genetics, 51, 59-65. [11]Han R L, Li Z J, Li M J, Li J Q, Lan X Y, Sun G R, Kang X T, Chen H. 2011. Novel 9-bp indel in visfatin gene and its associations with chicken growth. British Poultry Science, 52, 52-57. [12]Kershaw E E, Flier J S. 2004. Adipose tissue as an endocrine organ. Journal of Clinical Endocrinology and Metabolism, 89, 2548-2556. [13]Kloting N, Kloting I. 2005. Visfatin: gene expression in isolated adipocytes and sequence analysis in obese WOKW rats compared with lean control rats. B i o c h e m i c a l a n d B i o p h y s i c a l R e s e a r c h Communications, 332, 1070-1072. [14]Krzysik-Walker S M, Ocon-Grove O M, Maddineni S R. 2008. Is visfatin an adipokine or myokine? Evidence for greater visfatin expression in skeletal muscle than visceral fat in chickens. Endocrinology, 149, 1543-1550. [15]Le H H, Nott A, Moore M J. 2003. How introns influence and enhance eukaryotic gene expression. Trends in Biochemical Sciences, 28, 215-220. [16]Lemor A, Mielenz M, Altmann M. 2010. mRNA abundance of adiponectin and its receptors, leptin and visfatin and of G-protein coupled receptor 41 in five different fat depots from sheep. Journal of Animal Physiology and Animal Nutrition, 94, e96-e101. Mistry T, Digby J E, Raghu R, Joe J, Desai K M, Randeva H S. 2008. A novel role for the adipokine visfatin (pre-B cell colony-enhancing factor 1 (PBEF)/nicotinamide phosphoribosyltransferase (NMPRTase)) in prostate carcinogenesis. European Urology Supplements, 7, 964. Nei M, Li W H. 1979. Mathematic model for studying genetic variation in terms of restriction endonucleaes. Proceedings of the National Academy of Sciences of the United States of America, 76, 5269-5273. [17]Ons E, Gertler A, Buyse J. 2010. Visfatin gene expression in chickens is sex and tissue dependent. Domestic Animal Endocrinology, 38, 63-74. [18]Palin M F, Labrecque B, Beaudry D, Mayhue M, Bordignon V, Murphy B D. 2008. Visfatin expression is not associated with adipose tissue abundance in the porcine model. Domestic Animal Endocrinology, 35, 58-73. [19]Sethi J K, Vidal-Puig A. 2005. Visfatin: the missing link between intra-abdominal obesity and diabetes? Trends in Molecular Medicine, 11, 344-347. [20]Skop V, Kontrova K, Zidek V, Pravenec M, Kazdova L, Mikulik K, Sajdok J, Zidkova J. 2010. Autocrine effects of visfatin on hepatocyte sensitivity to insulin action. Physiological Research, 59, 615-618. [21]Sambrook J R D. 2002. Molecular Cloning: A Laboratory Manual. 3rd ed. China Science Press, Beijing, China. Walters R G, Jacquemont S, Valsesia A, de Smith A J, Martinet D, Andersson J. 2010. A new highly penetrant form of obesity due to deletions on chromosome 16p11. 2. Nature, 463, 671-677. [22]Wang M, Yu H, Chen H, Lan X Y, Zhang L Z, Zhao M, Lai X S, Wang X L, Wang K Y, Lei C Z, et al. 2009. Novel 35-bp insertion in visfatin gene in Chinese cattle. Molecular Biology, 43, 557-561. [23]Xie H, Tang S Y, Luo X H, Huang J, Cui R R, Yuan L Q, Zhou H D, Wu X P, Liao E Y. 2007. Insulin-like effects of visfatin on human osteoblasts. Calcified Tissue International, 80, 201-210. [24]Zrustova J, Knoll A, Urban T. 2009. The visfatin (NAMPT; PBEF1) gene polymorphisms and associations with meat performance traits in three pig breeds kept in the Czech Republic. Czech Journal of Animal Science, 54, 443-447. |